9468:TSEKadokawa Corporation Analysis
Data as of 2026-05-27 - not real-time
¥3,215.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: Kadokawa is trading at 3,215 JPY, below its 20‑day (≈3,399 JPY) and 50‑day (≈3,488 JPY) simple moving averages, signalling a bearish bias. The RSI hovers around 38, hinting at oversold conditions, while the MACD is in a bearish configuration with a negative histogram. Current price sits just above the identified support level of roughly 3,123 JPY and well below the resistance around 3,716 JPY.
Fundamental outlook: The stock is dramatically overvalued, with a trailing PE near 375 versus an industry average of about 17, and a DCF‑derived fair value of roughly 1,074 JPY—far beneath the market price. Revenue growth is modest at 12%, but profit margins are razor‑thin (<0.5%) and free cash flow is strongly negative. The dividend yield of 1.9% is backed by a payout ratio exceeding 300%, making it unsustainable despite the cash‑rich balance sheet. These factors combine to create a high‑risk profile despite a low beta and stable liquidity.
Fundamental outlook: The stock is dramatically overvalued, with a trailing PE near 375 versus an industry average of about 17, and a DCF‑derived fair value of roughly 1,074 JPY—far beneath the market price. Revenue growth is modest at 12%, but profit margins are razor‑thin (<0.5%) and free cash flow is strongly negative. The dividend yield of 1.9% is backed by a payout ratio exceeding 300%, making it unsustainable despite the cash‑rich balance sheet. These factors combine to create a high‑risk profile despite a low beta and stable liquidity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and price below key moving averages
- Extreme overvaluation relative to DCF fair value
- Support level near 3,123 JPY provides downside cushion
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward PE around 25 suggests earnings improvement
- Unsustainable dividend payout pressures cash flow
- Modest revenue growth but thin margins
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Trailing PE ~375 far exceeds industry norms
- Negative free cash flow and low ROE
- High valuation leaves limited upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth12.00%
Profit Margin0.45%
P/E Ratio374.7
ROE1.47%
ROA1.26%
Debt/Equity3.95
P/B Ratio1.9
Op. Cash Flow¥3.4B
Free Cash Flow¥-11489750016
Industry P/E17.2
Technical Analysis
TrendNeutral
RSI37.6
Support¥3,123.00
Resistance¥3,716.00
MA 20¥3,399.15
MA 50¥3,487.76
MA 200¥3,355.06
MACDBearish
VolumeStable
Fear & Greed Index91.96
Valuation
Fair Value¥1,073.98
Target Price¥3,151.43
Upside/Downside-1.98%
GradeOvervalued
TypeBlend
Dividend Yield1.89%
Risk Assessment
Beta0.27
Volatility32.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.